Wang, Y., Shen, A., Sun, J., Wang, X., Liu, H., Zhang, M., . . . Ding, J. (2016). Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells. Acta Pharmacol Sin.
Chicago Stili AlıntıWang, Yue-qin, et al. "Targeting Hsp90 With FS-108 Circumvents Gefitinib Resistance in EGFR Mutant Non-small Cell Lung Cancer Cells." Acta Pharmacol Sin 2016.
MLA AlıntıWang, Yue-qin, et al. "Targeting Hsp90 With FS-108 Circumvents Gefitinib Resistance in EGFR Mutant Non-small Cell Lung Cancer Cells." Acta Pharmacol Sin 2016.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..